Ameritas Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$14K	Buy	+1,564	New	+$14K	﹤0.01%	1882
2023 Q2	–	Sell	-1,244	Closed	-$9.69K	–	722
2023 Q1	$9.69K	Buy	+1,244	New	+$9.69K	﹤0.01%	1905